COMP <GO>
CNC vs MRK // ALTMAN Z-SCORE & DEBT/EQUITY
Centene Corporation (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: CNC 3
— MRK 11
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: MRK
LAST: $68.45 (-0.25%) • MKT CAP: $33.97B
balance-sheet
2.52
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
balance-sheet
5.19
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNC VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNC | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 8.10% | 74.80% | -66.70 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.00% | 20.70% | -51.70 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.72% | 3.42% | +9.30 | CNC | /fcf-yield <GO> |
| Operating Margin | -4.40% | 34.30% | -38.70 | MRK | /operating-margins <GO> |
| Net Profit Margin | -3.80% | 28.10% | -31.90 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 20.00% | 1.30% | +18.70 | CNC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.52 | 5.19 | -2.67 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.60% | +0.10 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.4 | 56.9 | -3.51 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.92 | +0.02 | CNC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 18.4x | +17.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $33.97B | $361.02B | -$327.05B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNC REV | MRK REV | CNC GROSS % | MRK GROSS % | CNC FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $174.58B | $65.01B | 8.1% | 74.8% | $4.32B | $12.36B |
| FY 2024 | $145.50B | $64.17B | 11.7% | 76.3% | -$490.0M | $18.10B |
| FY 2023 | $140.09B | $60.12B | 44.0% | 44.0% | $1.75B | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNC // BETA 0.94
MRK // BETA 0.92